vs
Acadia Healthcare Company, Inc.（ACHC）とNORTHERN OIL & GAS, INC.（NOG）の財務データ比較。上の社名をクリックして会社を切り替えられます
Acadia Healthcare Company, Inc.の直近四半期売上が大きい（$829.0M vs $610.2M、NORTHERN OIL & GAS, INC.の約1.4倍）。Acadia Healthcare Company, Inc.の純利益率が高く（0.5% vs -11.6%、差は12.1%）。Acadia Healthcare Company, Inc.の前年同期比売上増加率が高い（7.5% vs -72.6%）。過去8四半期でNORTHERN OIL & GAS, INC.の売上複合成長率が高い（4.3% vs 2.0%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
マラソン・オイル・コーポレーションは米国の炭化水素探査事業を営む企業である。2024年11月にコノコフィリップスに買収され、同社に統合された。
ACHC vs NOG — 直接比較
損益計算書 — Q1 FY2026 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $829.0M | $610.2M |
| 純利益 | $4.5M | $-70.7M |
| 粗利率 | — | — |
| 営業利益率 | — | — |
| 純利益率 | 0.5% | -11.6% |
| 売上前年比 | 7.5% | -72.6% |
| 純利益前年比 | -50.8% | -198.7% |
| EPS（希薄化後） | $0.05 | $-0.73 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | $610.2M | ||
| Q4 25 | $821.5M | $610.2M | ||
| Q3 25 | $851.6M | $556.6M | ||
| Q2 25 | $869.2M | $706.8M | ||
| Q1 25 | $770.5M | $602.1M | ||
| Q4 24 | $774.2M | $515.0M | ||
| Q3 24 | $815.6M | $753.6M | ||
| Q2 24 | $796.0M | $560.8M |
| Q1 26 | $4.5M | $-70.7M | ||
| Q4 25 | $-1.2B | $-70.7M | ||
| Q3 25 | $36.2M | $-129.1M | ||
| Q2 25 | $30.1M | $99.6M | ||
| Q1 25 | $8.4M | $139.0M | ||
| Q4 24 | $32.6M | $71.7M | ||
| Q3 24 | $68.1M | $298.4M | ||
| Q2 24 | $78.5M | $138.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 80.4% | ||
| Q3 25 | — | 78.7% | ||
| Q2 25 | — | 82.8% | ||
| Q1 25 | — | 81.1% | ||
| Q4 24 | — | 77.4% | ||
| Q3 24 | — | 85.8% | ||
| Q2 24 | — | 82.0% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | -5.5% | ||
| Q3 25 | 4.7% | -22.6% | ||
| Q2 25 | 5.8% | 24.9% | ||
| Q1 25 | 1.7% | 38.1% | ||
| Q4 24 | 4.9% | 25.8% | ||
| Q3 24 | 12.1% | 57.6% | ||
| Q2 24 | 13.4% | 39.0% |
| Q1 26 | 0.5% | -11.6% | ||
| Q4 25 | -143.3% | -11.6% | ||
| Q3 25 | 4.3% | -23.2% | ||
| Q2 25 | 3.5% | 14.1% | ||
| Q1 25 | 1.1% | 23.1% | ||
| Q4 24 | 4.2% | 13.9% | ||
| Q3 24 | 8.4% | 39.6% | ||
| Q2 24 | 9.9% | 24.7% |
| Q1 26 | $0.05 | $-0.73 | ||
| Q4 25 | $-12.98 | $-0.67 | ||
| Q3 25 | $0.40 | $-1.33 | ||
| Q2 25 | $0.33 | $1.00 | ||
| Q1 25 | $0.09 | $1.39 | ||
| Q4 24 | $0.36 | $0.71 | ||
| Q3 24 | $0.74 | $2.96 | ||
| Q2 24 | $0.85 | $1.36 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $14.3M |
| 総負債低いほど良い | $2.5B | — |
| 株主資本純資産 | $2.0B | $2.1B |
| 総資産 | $5.5B | $5.4B |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | $14.3M | ||
| Q4 25 | $133.2M | $14.3M | ||
| Q3 25 | $118.7M | $31.6M | ||
| Q2 25 | $131.4M | $25.9M | ||
| Q1 25 | $91.2M | $33.6M | ||
| Q4 24 | $76.3M | $8.9M | ||
| Q3 24 | $82.1M | $34.4M | ||
| Q2 24 | $77.2M | $7.8M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $2.4B | ||
| Q3 25 | $2.3B | $2.3B | ||
| Q2 25 | $2.3B | $2.4B | ||
| Q1 25 | $2.2B | $2.3B | ||
| Q4 24 | $2.0B | $2.4B | ||
| Q3 24 | $1.9B | $2.0B | ||
| Q2 24 | $1.8B | $1.9B |
| Q1 26 | $2.0B | $2.1B | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $3.1B | $2.2B | ||
| Q2 25 | $3.1B | $2.4B | ||
| Q1 25 | $3.0B | $2.4B | ||
| Q4 24 | $3.1B | $2.3B | ||
| Q3 24 | $3.0B | $2.3B | ||
| Q2 24 | $3.0B | $2.1B |
| Q1 26 | $5.5B | $5.4B | ||
| Q4 25 | $5.5B | $5.4B | ||
| Q3 25 | $6.4B | $5.5B | ||
| Q2 25 | $6.3B | $5.7B | ||
| Q1 25 | $6.1B | $5.7B | ||
| Q4 24 | $6.0B | $5.6B | ||
| Q3 24 | $5.9B | $5.1B | ||
| Q2 24 | $5.7B | $4.7B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 1.13× | ||
| Q3 25 | 0.74× | 1.05× | ||
| Q2 25 | 0.74× | 0.98× | ||
| Q1 25 | 0.72× | 0.96× | ||
| Q4 24 | 0.64× | 1.02× | ||
| Q3 24 | 0.62× | 0.84× | ||
| Q2 24 | 0.62× | 0.91× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | $312.6M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $43.2M |
| FCFマージンFCF / 売上 | — | 7.1% |
| 設備投資強度設備投資 / 売上 | — | 31.5% |
| キャッシュ転換率営業CF / 純利益 | 13.78× | — |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | $312.6M | ||
| Q4 25 | $-86.3M | $312.6M | ||
| Q3 25 | $73.2M | $423.1M | ||
| Q2 25 | $133.5M | $362.1M | ||
| Q1 25 | $11.5M | $407.4M | ||
| Q4 24 | $116.7M | $290.3M | ||
| Q3 24 | $163.1M | $385.8M | ||
| Q2 24 | $171.1M | $340.5M |
| Q1 26 | — | $43.2M | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — |
| Q1 26 | — | 7.1% | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | 31.5% | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | 3.64× | ||
| Q1 25 | 1.37× | 2.93× | ||
| Q4 24 | 3.58× | 4.05× | ||
| Q3 24 | 2.39× | 1.29× | ||
| Q2 24 | 2.18× | 2.46× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
NOG
| Oil and Gas Sales | $447.7M | 73% |
| Gain on Commodity Derivatives, Net | $159.3M | 26% |
| Other Revenue | $3.1M | 1% |
